Related references
Note: Only part of the references are listed.A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties
Aurelie Tchoghandjian et al.
BRAIN PATHOLOGY (2010)
Presence of pluripotent CD133(+) cells correlates with malignancy of gliomas
Niklas Thon et al.
MOLECULAR AND CELLULAR NEUROSCIENCE (2010)
Prognostic Impact of O6-Methylguanine-DNA Methyltransferase Silencing in Patients With Recurrent Glioblastoma Multiforme Who Undergo Surgery and Carmustine Wafer Implantation A Prospective Patient Cohort
Philippe Metellus et al.
CANCER (2009)
Neurosphere Formation Is an Independent Predictor of Clinical Outcome in Malignant Glioma
Dan R. Laks et al.
STEM CELLS (2009)
CD133 expression and cancer stem cells predict prognosis in high-grade oligodendroglial tumors
Dagmar Beier et al.
BRAIN PATHOLOGY (2008)
Temozolomide preferentially depletes cancer stem cells in glioblastoma
Dagmar Beier et al.
CANCER RESEARCH (2008)
Targeting cancer stem cells through L1CAM suppresses glioma growth
Shideng Bao et al.
CANCER RESEARCH (2008)
Cancer Stem Cell Analysis and Clinical Outcome in Patients with Glioblastoma Multiforme
Roberto Pallini et al.
CLINICAL CANCER RESEARCH (2008)
Stem cell marker CD133 affects clinical outcome in glioma patients
Felix Zeppernick et al.
CLINICAL CANCER RESEARCH (2008)
Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients
Mingyu Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Identification of A2B5+CD133-tumor-initiating cells in adult human gliomas
Alfred T. Ogden et al.
NEUROSURGERY (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma
Gentao Liu et al.
MOLECULAR CANCER (2006)
Chemotherapy resistance of glioblastoma stem cells
A. Eramo et al.
CELL DEATH AND DIFFERENTIATION (2006)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Mechanisms of disease: Neural stem cells and the origin of gliomas
N Sanai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
MGMT gene silencing and benefit from temozolomide in glioblastoma
ME Hegi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Development of gliomas: potential role of asymmetrical cell division of neural stem cells
F Berger et al.
LANCET ONCOLOGY (2004)
Identification of human brain tumour initiating cells
SK Singh et al.
NATURE (2004)
Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents
M Esteller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
